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Abstract
Background: The recommended interval between updates for systematic reviews included in The Cochrane Library is 2
years. However, it is unclear whether this interval is always appropriate. Whereas excessive updating wastes time and
resources, insufficient updating allows out-of-date or incomplete evidence to guide clinical decision-making. We set out to
determine, for Cochrane pregnancy and childbirth reviews, the frequency of updates, factors associated with updating, and
whether updating frequency was appropriate.
Methodology/Principal Findings: Cochrane pregnancy and childbirth reviews published in Issue 3, 2007 of the Cochrane
Database of Systematic Reviews were retrieved, and data were collected from their original and updated versions.
Quantitative changes were determined for one of the primary outcomes (mortality, or the outcome of greatest clinical
significance). Potential factors associated with time to update were assessed using the Cox proportional hazard model.
Among the 101 reviews in our final sample, the median time before the first update was 3.3 years (95% CI 2.7–3.8). Only
32.7% had been updated within the recommended interval of 2 years. In 75.3% (76/101), a median of 3 new trials with a
median of 576 additional participants were included in the updated versions. There were quantitative changes in 71% of the
reviews that included new trials (54/76): the median change in effect size was 18.2%, and the median change in 95% CI
width was 30.8%. Statistical significance changed in 18.5% (10/54) of these reviews, but conclusions were revised in only
3.7% (2/54). A shorter time to update was associated with the same original review team at updating.
Conclusions/Significance: Most reviews were updated less frequently than recommended by Cochrane policy, but few
updates had revised conclusions. Prescribed time to update should be reconsidered to support improved decision-making
while making efficient use of limited resources.
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Introduction
Systematic reviews have become increasingly popular in recent
years [1] as the best source of evidence for health care
practitioners and others. The scientific process used to produce
a systematic review has put these reviews at the centre of health
care systems in many countries. At their core systematic reviews
aggregate evidence from primary studies, globally. Clinicians can
use these reviews to guide patient care and develop clinical
practice guidelines. Likewise, decision makers use reviews to help
make informed (and evidence based) decisions at all levels of the
health care system [2].
When information about an intervention is dynamic and
changes over time [3], systematic reviews provide an important
source of up-to-date information to support clinical decision-
making [4]. Systematic reviews are less useful if they are not up to
date. Recent studies have reported that 37% to 70% of systematic
reviews in The Cochrane Library have been updated [5,6]. Of the
Cochrane reviews (CRs) that are updated, only a small proportion
(3% to 9%) lead to changes to results and conclusions [5,7–9].
Some updates result in increased precision and statistical
significance of the primary outcomes; in others, the reverse effect
occurs. The 2-year updating policy of The Cochrane Collabora-
tion [10] might not be appropriate to all CRs. Frequent updates to
CRs might be unnecessary and waste resources; on the other
hand, less frequent updates could render the results of CRs
outdated, misleading, or both [4].
A recent analysis by Shojania and colleagues [11] of a sample of
systematic reviews showed that the median duration of survival
before the need for an update was signaled was 5.5 years (95% CI
4.36–7.67). A signal that the evidence was out of date occurred
within 2 years for 23% of reviews and within 1 year for 15% of
reviews. Shorter survival times were seen in reviews that addressed
cardiovascular topics. For the purposes of our analysis, updates
were deemed to be warranted if they showed a 50% or greater
change in quantitative results, including a change in statistical
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systematic reviews in the Cochrane Database of Systematic
Reviews cover many clinical areas, and the ideal interval for
updating may vary from one area to another, depending on factors
such as the number of new trials and participants, search strategies
and databases, and the time to publication of new trials [4].
The Cochrane Pregnancy and Childbirth Group (PCG) was, in
October 1992, the first to register with the Cochrane Collabora-
tion [12]. The number of PCG reviews and protocols has been
increasing continuously since that time [13,14]. The survival time
of reviews before they are updated, potential factors that trigger
updates and quantitative criteria for updating might differ from
those in other clinical areas. The purpose of this study was
to identify the time to update and to describe the status of
updated PCG reviews. Changes in effect size, confidence interval
(CI) width, and statistical significance were quantified to
determine whether they were of sufficient importance to warrant
the update. Potential factors associated with updating time were
also assessed.
Methods
One investigator (WJ) searched for the PCG reviews in the
Cochrane Library issue3, 2007 using the query topic ‘‘Pregnancy
and Childbirth’’. All 381 registered PCG reviews formed the
original retrospective cohort.
Criteria for identifying updated reviews and their original
versions
Reviews were identified as updates if their first published version
had appeared before 2007 Issue 3 and their latest versions were of
this issue. The updated reviews were identified from Archie the
Cochrane Collaboration’s Information System (IMS) website. In
the history page of each review, if the version was not ‘the first
published’, it was identified as an updated version. The original
versions of reviews identified as updates were then searched from
previous Cochrane Library CDs using the digital object identifier
(DOI) number.
Main outcome and predicting factors
The main outcome, time to update, was defined as the duration
from the date of first publication to the date of the most recent
substantive amendment (update). Both dates were reported on the
‘‘cover’’ sheet of each review.
Factors potentially associated with time to update were clinical
topic classification, number of additional trials, number of
additional participants, the use of additional databases, new
search strategies, author affiliation, and country of origin. PCG
topics were classified as follows: (1) antenatal care; (2) pregnancy
complications; (3) fetal complications; (4) intrapartum issues; or (5)
postpartum issues. Author affiliation of first and corresponding
authors was classified as academic (e.g., university-based) or non-
academic. The non-academic category included hospitals, medical
practices, health research institutes and other organizations such
as the World Health Organization. Economic status [15] was used
to classify the country of origin as ‘‘developed’’ or ‘‘developing.’’
Changes in the review team were classified as follows: (1) same as
original version; (2) included new author(s); (3) changed author(s);
or (4) changed new team.
Quantitative change
Quantitative change was defined as a change in the updated
version relative to the results of the original meta-analytic results,
in the magnitude and/or direction of effect, statistical significance,
relative effect size, or width of the CI. Quantitative change was not
measured for reviews which did not contain a meta-analysis, had
no or only one additional trial, or generated new comparisons. For
reviews with more than 1 primary outcome, the primary mortality
outcome or the outcome of greatest clinical significance (e.g.,
preterm labour, low birth weight, prolongation of pregnancy, etc.)
was used. The outcome of greatest clinical significance was
selected by a gynaecologist of Khon Kaen university hospital.
Specific criteria for quantitative changes were as follows:
1.Change in effect size. The effect size was deemed to have
changed when the result of the updated meta-analysis showed a
relative change in effect size when compared with the result
reported in the first published version. The change in effect size
was calculated as the ratio of (A) the difference between the
updated and the original pooled treatment effect to (B) the
original pooled treatment effect. The direction of the change in
effect size was also observed.
2.Change in the width of the effect size CI. The change in
CI width was calculated as the ratio between the difference
between (A) the updated and original CI width to (B) the
original CI width.
3.Change in statistical significance. This was defined as a
change from a statistically significant finding for the primary
outcome to a non-statistically significant finding, or the reverse.
To eliminate borderline changes in statistical significance, a
change from p=0.04 to p=0.06 or from p=0.06 to p=0.04
was not counted as a change in statistical significance.
A quantitative change was detected when at least one criterion
was met. The changes were classified into 3 groups: no change;
minor changes (at least 1 quantitative change, but with no effect on
the conclusion); and major changes (at least 1 quantitative change
that affected the conclusion).
Change in meta-analysis conclusions
The conclusion of the meta-analysis was considered to have
changed when the interpretation of findings in the updated review
was substantially altered from the interpretation of the original
findings. A change in style or wording that did not alter the
substance or meaning of the conclusion was not considered a
change in the conclusion [5,16].
Data extraction
Data on the main outcome and other characteristics were
collected (WJ) from the original systematic review and its
associated updates. These data included author affiliations
(including country), issue of publication, date of most recent
substantive amendment, update frequency, search strategies and
search resources, number of included trials and participants, and
summary statistics (e.g., relative risk), including the CIs of the effect
sizes of the primary outcomes. These data were extracted using a
specially designed data collection form. A second member of the
research team (ML), using the same methods, independently
collected these data from a random sample of 20 updated reviews;
the 2 sets of results were compared for the purpose of validation.
Discrepancies, such as differences in primary outcome and
changes in conclusion, between the 2 sets of extracted data were
resolved by consensus.
Analysis of time to update and associated factors
Kaplan–Meier survival curves were used to estimate an average
time to update and its 95% CI [17]. A Cox proportional hazards
model was applied to examine the association between the
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The effect of each factor is presented as a hazard ratio (HR) and
95% CI. The statistical software Stata, version 10.0 (StataCorp
LP, College Station, Tex.), was used to complete the data analyses.
Results
From the retrospective cohort of 381 PCG reviews we excluded
105: of these, 37 had been withdrawn from the Cochrane
database, and 68 were still protocols. There were 276 completed
PCG reviews in the 2007 volume, Issue 3. Of these, 111 were
updates according to our criteria, i.e. the latest versions of the
study cohort were different from those of the first published
version. However, examination of the full texts revealed errors in
10 reviews in the dates of first publication and/or last amendment.
Our analysis was therefore limited to 101 updated reviews
(Fig. 1).
Characteristics of updated PCG reviews
The 101 PCG reviews had been updated 1 to 6 times; most had
been updated only once (67.3%, 68/101). A small number of
reviews had been updated 2 or more times: (33 reviews had been
updated at least twice, 11 reviews had been updated 3 or more
times, and 4 reviews had been updated 4 or more times). In the
following we present the survival time to update, quantitative
changes, and factors associated with time to update for reviews at
their first update only.
Among the 101 reviews, the largest proportion of updates was
seen in reviews that addressed intrapartum issues (33.7%, 34/101),
while 24.8% (25/101) addressed fetal complications and only 5%
(5/101) addressed postpartum issues. The majority of the
corresponding authors who conducted the reviews were in
academic institutions (71.3%, 72/101), and 93.1% (94/101) were
in developed countries. From the updates, 29.7% (30/101)
included/changed at least one new review author and 3.0% (3/
101) had a new review team. In 27.7% (28/101) of the updates,
new databases were searched, and 24.8% (25/101) used new
search strategies. Most reviews were updated by the addition of
new trials (75.3%, 76/101), with a median of 3 trials (IQR 1–5)
and a median of 576 new participants (IQR 180–1386). Of these
76 reviews, 71% (54/76) updated the primary outcomes (Table 1).
For the 25 updated reviews that did not include additional new
trials and participants in the primary outcomes, 40.0% (10/25)
added new comparisons, or subgroup analyses.
Time to the first update
The median time to the first update was 3.3 years (95% CI 2.7–
3.8) for the 101 updated reviews (Fig. 2). Only 12.9% (13/101) of
the reviews were updated within 1 year, and 32.7% (33/101) were
updated within 2 years. Intrapartum issues had the fastest time to
update, with a median of 2.5 years (95% CI 1.6–3.6), followed by
postpartum issues, with a median of 2.8 years (95% CI 2.1–3.6,
Table 2).
For the 76 updated reviews that included new trials, the median
time to first update was also 3.3 years (95% CI 2.5–4.0), as
compared with 2.5 years (95% CI 0.6–4.4) in those 25 updated
reviews that did not include new information (Fig. 3 and Table 2).
This difference in time to update was not statistically significant
(p=0.57). Of the 76 updated reviews with additional trials, 10.5%
(8/76) had been updated for the first time within 1 year, and
28.9% (22/76) within 2 years. Among updated reviews that
included new trials, the fastest updates were seen in reviews of
intrapartum issues (median 2.8 years; 95% CI 1.8–3.7). Among
updated reviews that did not add new trials, the fastest updates
were seen in those that concerned fetal complications (median 1.5
years; 95% CI 0.5–6.3). The reviews updated by the same original
Figure 1. Flow diagram of selection of reviews for analysis.
doi:10.1371/journal.pone.0011553.g001
Table 1. Characteristics of updated reviews at first update
period (101 reviews).
Characteristic Number (%)
Topic classification
Antenatal care 17 (16.8)
Fetal complications 25 (24.8)
Intrapartum issues 34 (33.7)
Pregnancy complications 20 (19.8)
Postpartum issues 5 (5.0)
Author affiliation
Academic 72 (71.3)
Non-academic 29 (28.7)
Author country
Developed country 94 (93.1)
Developing country 7 (6.9)
Review team
Same original version 68 (67.3)
Included new author(s) 19 (18.8)
Changed author(s) 11 (10.9)
New review team 3 (3.0)
Additional new database searched 28 (27.7)
New search strategies 25 (24.8)
Additional trials included 76 (75.3)
Median of included trials (q1–q3)
*=3 (1–5) trials
Median of included participants (q1–q3)
*=576 (180–1386)
participants
With quantitative change in primary outcome
* 54 (71.0)
With change in conclusions
* 2 (2.6)
*For 76 reviews that included new trials.
doi:10.1371/journal.pone.0011553.t001
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(95% CI 1.8–3.2). The longest time to update was found in
updated reviews by a new review team, with a median of 8.6 years
(95% CI 4.2–13.0, Table 3).
Quantitative changes at first update
In examining the details of updating (Table 4), we found that, of
the 76 reviews that included additional trials, 25.0% (19/76)
updated the original meta-analyses with new data and 28.9% (22/
76) generated new comparisons. Both updated meta-analyses and
new comparisons were present in 46% (35/76) of the updated
reviews. Of the 76 reviews that included new trials, 71% (54/76)
showed a quantitative change in the updated meta-analysis. The
median of additional new trials was 1 (IQR 1–2 trials), and the
median of increasing participants was 318 (IQR, 132–1193
participants).
Of the 54 updated reviews that showed quantitative changes,
the median change in the estimate of effect size was 18.2% (95%
CI 13.2%–23.1%). Of these 54 reviews, 19 (35.2%), showed a
change in effect size of between 10.0% and 24.9%. Only 9.3% (5/
54) of reviews that presented risk ratios showed a change in the
direction of the effect; in 2 reviews, these estimates changed from a
protective to a risk effect, while in the other 3 the change was in
the opposite direction. However, there was no change in the
conclusions in comparison with those of the original reviews. The
median change in 95% CI width for these 54 reviews was 30.8%
(95% CI 19.4%–32.9%). A change in the 95% CI width of
between 25% and 49.9% was seen in 33.3% (18/54), and a change
in statistical significance was seen in 18.5% (10/54). Of these, the
findings of 8 reviews changed from non-significance (p.0.05) to
significance (p,0.05). Of the 54 reviews with quantitative changes,
those with a higher number of participants than the original
versions showed a greater than 50% change in effect size and in
the width of the 95% CI. A similar degree of change was observed
with respect to statistical change. Results and the interpretation of
conclusions were affected in only 3.7% (2/54) of the reviews with
quantitative changes. These 2 reviews had quantitative changes
higher than 50%; the degree of change in effect size for these
reviews was 53.8% and 62.9%, respectively, and of that of change
in the width of the 95% CI, 76.5% and 88.7%, respectively. These
2 reviews also had the shortest time to first update among the 54
with quantitative changes: 1.08 and 1.58 years, respectively,
whereas the median time to update among the other 52 was 3.3
years (95% CI 2.4–5.3).
Figure 2. Kaplan–Meier curves with 95% confidence interval for sample of 101 reviews at first update.
doi:10.1371/journal.pone.0011553.g002
Table 2. Time to first update of the 101 updated reviews, by topic classification and presence or absence of additional trials.
Overall
With additional
trials
Without
additional trials
Reviews, n
Years to update,
median (95% CI) Reviews, n
Years to update,
median (95% CI) Review, n
Years to update,
median (95% CI)
Overall 101 3.3 (2.7–3.8) 76 3.3 (2.5–4.0) 25 2.5 (0.6–4.4)
CPC topic classification
Antenatal care 17 5.5 (2.7–8.3) 14 5.6 (1.4–9.8) 3 0.5, 2.5, 8.6
*
Fetal complications 25 3.9 (0.9–6.9) 14 3.9 (2.5–5.3) 11 1.5 (0.5–6.3)
Intrapartum issues 34 2.5 (1.6–3.6) 28 2.8 (1.8–3.7) 6 1.8 (0.5–3.1)
Postpartum issues 5 2.8 (2.1–3.6) 5 2.8 (2.1–3.6) – –
Pregnancy complications 20 3.3 (0.6–6.1) 15 3.3 (0.5–6.2) 5 3.3 (2.7–3.8)
*Actual values.
doi:10.1371/journal.pone.0011553.t002
Update of Systematic Reviews
PLoS ONE | www.plosone.org 4 July 2010 | Volume 5 | Issue 7 | e11553Predictive factors for time to first update
Factors that showed a statistically significant association with the
time to first update as detected by univariate analysis were the
inclusion of additional trials (HR 0.51; 95% CI 0.32–0.83),
searching an additional database (HR 0.59; 95% CI 0.38–0.92),
topic area in intrapartum issues (HR 1.86; 95% CI 1.03–3.37) and
changed new review team (HR 0.20; 95% CI 0.6–0.66). These 4
factors were subsequently added to the Cox proportional hazard
model. A shorter time to update was associated with the same
original review team in the update (Table 5).
Discussion
Our study of a retrospective cohort of updated PCG reviews
was conducted to ascertain the average time to update and factors
associated with updating. The results showed a median time to
first update of 3.3 years (95% CI 2.8–4.6). Only a third of reviews
had undergone a first update within 2 years, the Cochrane
Collaboration’s recommended interval for the updating of reviews.
Three quarters of the updated reviews (75%; 76/101) added new
trials (a median of 3 trials, IQR 1–5 trials) and participants (a
median of 576 participants, IQR 180–1386 participants). Among
the updated reviews that included additional trials at the first
update, 71% (54/76) showed a quantitative change in the updated
meta-analyses. However, only 2 of those updates resulted in major
quantitative changes that also altered the conclusions. A shorter
time to update was associated with maintaining the original review
team in the update.
The Cochrane Collaboration aims to support up-to-date,
evidence-based decision-making in health care by regularly
updating the systematic reviews in its database. An interval of 2
years after the initial publication has been recommended as an
appropriate time before the first update. This enables Cochrane
reviews to provide rigorous up-to-date evidence for decision-
making in health care interventions. Our study showed that two
thirds (68/101) of the PCG reviews published in 2007, Issue 3,
had been updated after a longer interval than the recommended
period of 2 years. This might reflect a low frequency of new
trials in the areas of pregnancy and childbirth. Limited
resources and competing time demands can also make it
difficult for the members of a review group to carry out
frequent updates.
Our results show that reviews involving a new author(s) or new
review team in the update took longer to update (more than 5
years). This finding suggests that there are personnel and time
constraints hindering the updating process that contribute to
reviews being out of date. Similar results have been reported
elsewhere [18]. Some reviews may have been conducted by
individual researchers who may lack necessary resources and/or
academic support for updating. By assisting in the updating
process through developing strategies for monitoring the updating
of reviews, reminding reviewers about updating, and supporting
reviewers in the updating process, Cochrane review groups might
help to keep the Cochrane database up to date.
For the 76 updated reviews in which new trials were added, our
results indicate that the median time to update of the 22 reviews
Figure 3. Kaplan–Meier curves for reviews with and without additional trials at first update.
doi:10.1371/journal.pone.0011553.g003
Table 3. Time to first update of the 101 updated reviews, by
review team.
Reviews, n Years to update, median (95% CI)
Review team
Same original version 68 2.5 (1.8–3.2)
Included new author(s) 19 6.8 (6.1–7.5)
Changed authors(s) 11 5.8 (4.2–7.4)
New review team 3 8.6 (4.2–13.0)
doi:10.1371/journal.pone.0011553.t003
Table 4. Characteristics of updated reviews that included
additional trials at first update (76 reviews).
Characteristic n (%)
Added new data to original meta-analysis 19 (25.0)
Made new comparisons 22 (28.9)
Added new trials to original meta-analysis
and made new comparisons
35 (46.1)
Total 76 (100.0)
doi:10.1371/journal.pone.0011553.t004
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6.6), which was much longer than that for the 54 reviews with no
new database, 2.9 years (95% CI 2.2–3.3). Perhaps this is an
indication that the addition of information from a new database is
time-consuming; however, there may be room for improvement in
search strategies and the processing of information from new
databases.
Our results showed details of updating times of reviews within
each topic category. We found, in all topic categories, updating
times were higher in reviews with additional new trials than in
those without new trials. Additionally, the updating interval for
reviews with additional new trials was greater than 2 years for all
categories. We found that the time to update for reviews with
additional new trials of intrapartum issues and postpartum issues
was less than for other topic categories. However, these differences
were not statistically significant, supporting our premise that trial
development in the area of pregnancy and childbirth is slow.
Our results showed that the median time to the first update was
3.3 years (95% CI, 2.8–4.6). This interval is shorter than the 5.5
years (95% CI, 4.6–7.6 years) reported by Shojania and colleagues
[11]. Our study was limited to Cochrane Pregnancy and
Childbirth reviews, while the sample used by Shojania and
colleagues (100 meta-analyses indexed in the ACP Journal Club
from 1995 to 2005), was more general, and included only a
minority (27%) of Cochrane reviews. Moreover, Shojania and
colleagues identified the time by which reviews were out of date on
the basis of qualitative signals that evidence is out of date. In the
current study, we use the event of a revised publication to identify
time to update, rather than identifying when reviews become out
of date. If we had used Shojania and colleagues’ criteria, the
‘‘survival time’’ found in our sample of PCG reviews would be
have been longer. Only 33.3% of the updated reviews that showed
a quantitative change (18/54) showed a change of 50% or greater,
the cut-off used by Shojania and colleagues to identify reviews that
had become out of date. By this criterion, the median survival time
for reviews in our sample would have been 7.2 years (95% CI, 6.3–
8.0). A previous study of CRs published from 1998, Issue 2, to
2002, Issue 2 indicated that 9% of updated reviews had revised
conclusions [5]. Our study found that only 3.7% (2/54) of the
updated reviews with quantitative changes also had revised
conclusions. This might be because our sample was drawn from
only 1 issue, and from only 1 of the 52 Cochrane review groups.
However, the fact that the 2 reviews with revised conclusions
showed quantitative changes of more than 50% in their meta-
analysis of the primary outcome lends some support to the use by
Shojania and colleagues of a 50% change as a cut-off value for an
out-of-date review [11].
Our results show that, although 76 reviews had been updated
with additional new trials, in 29% of these (22/76) no qualitative
changes could be identified. This was because they did not add
new data to the meta-analysis of original primary outcomes but,
rather, added new comparisons to the updated version. From the
54 updated reviews that showed quantitative changes, around one
fourth showed a change in effect size or in 95% CI width, and one
fifth showed a change in statistical significance. A few reviews (5/
54) showed a change in the direction of the estimate of risk ratios,
but these changes were around 1 and still resulted in the same
findings for statistical significance as the original meta-analyses.
The highest percentage of change in effect sizes and 95% CI width
were seen in updated reviews with the highest percentage of new
trials and participants. Finally, we found only 2 reviews in which
quantitative changes much greater than 50% led to altered
conclusions. These results reflect a need to ascertain the optimal
interval for the updating of PCG reviews. However, the
recommended 2-year interval for updates should be re-evaluated
to determine whether it is in fact appropriate in the area of PCG
reviews.
There are limitations in our study: 1) we focused on systematic
reviews that included meta-analyses. Our study does not address
updating systematic reviews without meta-analyses or reviews for
which there appears to be a robust evidence base which
definitively answers questions about effectiveness and/or safety
of an intervention. For reviews where there is already an ‘answer,’
it is unlikely that there will be new primary research and updating
the systematic review may not be necessary. This view is in
keeping with the Cochrane Collaboration’s policy of maintaining
current and up to date reviews. 2) We did not incorporate
information on qualitative changes that were relevant to clinical
contents. This was because of the difficulty in searching for this
type of information within the study period. 3) We did not consider
secondary outcomes because they were diverse and many have few
studies contributing to a meta-analysis. Secondary outcomes are
usually not as important as the primary outcome for answering the
review question. 4) We did not assess changes in review
methodology (i.e. in the Cochrane Handbook guidance) as a
potential factor for updating. This was because of difficulty in
identifying the Handbook guidance versions used by the review
authors before 2007 Issue 3. Our study collected updated reviews
that appeared before this time, and finally. 5) We focused only on
a cohort of PCG reviews, and our findings might not be
generalizable to reviews in other clinical areas, especially those
in which the pace of new trials development is different.
Our study provides food for thought for those who produce,
publish and use PCG reviews. Most of these reviews have been
updated less frequently than the Cochrane updating policy
recommendation stipulates. Very few updated reviews had
changed conclusions, and those that did showed large quantitative
changes. To ensure that PCG reviews are up to date, proactive
strategies should be developed and implemented. Refinements to
the Cochrane review guidelines could help to harmonize
international standards in certain aspects of the updating process
Table 5. Factors predicting time to first update of PCG
reviews.
Factor Adjusted HR (95% CI)
Topic classification
Antenatal care Reference
Pregnancy complications 0.56 (0.23–1.34)
Fetal complications 1.02 (0.45–2.28)
Intrapartum issues 1.55 (0.77–3.13)
Postpartum issues 2.12 (0.72–6.24)
Additional trials ($3 trials; median) 0.61 (0.35–1.06)
Additional participants ($576 participants;
median)
1.92 (1.05–3.49)
Additional database 0.79 (0.44–1.41)
Review team
Same original version Reference
Included new author(s) 0.17 (0.79–0.38)
Changed author(s) 0.27 (0.12–0.61)
New review team 0.13 (0.03–0.73)
HR= hazard ratio; CI = confidence interval.
doi:10.1371/journal.pone.0011553.t005
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optimal interval between updates should be developed to help
support well-informed decision-making in pregnancy and child-
birth care.
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